Evidence map›Paper›PMID 31572682›Full record

ArticleFrontiers in oncology2019

Overexpression of p16

Nathalie Arians, Elena-Sophie Prigge, Tereza Nachtigall, Miriam Reuschenbach, Stefan Alexander Koerber, Juergen Debus, Magnus von Knebel Doeberitz, Katja Lindel

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. The impact of p16Archives of gynecology and obstetrics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Nathalie AriansDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Elena-Sophie PriggeDepartment of Applied Tumour Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Tereza NachtigallDepartment of Gynecology and Obstetrics, Heidelberg University Hospital, Heidelberg, Germany.
Miriam ReuschenbachDepartment of Applied Tumour Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Stefan Alexander KoerberDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Juergen DebusDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Magnus von Knebel DoeberitzDepartment of Applied Tumour Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Katja LindelDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
German Cancer Research Center · DEHeidelberger Institut für Radioonkologie · DEHeidelberg University · DEStädtisches Klinikum Karlsruhe · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

human papillomavirusp16INK4aprognostic factorsradiotherapyvulvar squamous cell carcinoma

Identifiers

PMID31572682
PMCPMC6749023
OpenAlexW2970121740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.